Liu Xinyuan
Liu Xinyuan | |||||||
|---|---|---|---|---|---|---|---|
| Born | November 1927 (age 98) Hunan, China | ||||||
| Alma mater | Nankai University Shanghai Institute of Biochemistry | ||||||
| Known for | Cancer-Targeting Gene-Viro-Therapy | ||||||
| Awards | Ho Leung Ho Lee Prize | ||||||
| Scientific career | |||||||
| Fields | Molecular biology | ||||||
| Institutions | Shanghai Institute of Biochemistry and Cell Biology Zhejiang Sci-Tech University | ||||||
| Chinese name | |||||||
| Traditional Chinese | 劉新垣 | ||||||
| Simplified Chinese | 刘新垣 | ||||||
| |||||||
Liu Xinyuan (Chinese: 刘新垣; born November 1927), or Xin-Yuan Liu, is a Chinese molecular biologist. He is a professor of the Shanghai Institute of Biochemistry and Cell Biology and the founding director of the Xinyuan Institute of Medicine and Biotechnology at Zhejiang Sci-Tech University. His research is focussed on cancer, super interferon therapy, and gene therapy. He is an academician of the Chinese Academy of Sciences, the National Academy of Sciences of Ukraine, and The World Academy of Sciences. He has won more than 30 awards including the Ho Leung Ho Lee Prize.